<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02920983</url>
  </required_header>
  <id_info>
    <org_study_id>EX-MTKG-74 (C16-596)</org_study_id>
    <nct_id>NCT02920983</nct_id>
  </id_info>
  <brief_title>A Clinical Comparison of Three Soft Daily Disposable Contact Lenses</brief_title>
  <official_title>A Clinical Comparison of Three Soft Daily Disposable Contact Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coopervision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coopervision, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to compare the clinical performance of the somfilcon A, nelfilcon A II 2 and
      omafilcon A II 2 daily disposable contact lenses.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a randomised, subject-masked, crossover, bilateral study, controlled by cross
      comparison. Fifty subjects will use each lens type for a week in random sequence. Follow-up
      visits for each lens will be performed after one week of wear. Lenses will be worn on a daily
      wear, daily disposable wear schedule.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Actual">February 2017</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ocular Physiology</measure>
    <time_frame>1 week</time_frame>
    <description>Ocular physiology assessment of by biomicroscopy (Scale 0-4, 0.25 steps, 0=normal, 4=severe).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lens Fit - Horizontal Centration</measure>
    <time_frame>1 week</time_frame>
    <description>Horizontal centration will be assessed for the following regions: extremely nasal, slightly nasal, optimum, slightly temporal, extremely temporal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lens Fit - Vertical Centration</measure>
    <time_frame>1 week</time_frame>
    <description>Vertical centration will be assessed for the following regions: extremely nasal, slightly nasal, optimum, slightly temporal, extremely nasal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lens Fit - Corneal Coverage</measure>
    <time_frame>1 week</time_frame>
    <description>Corneal coverage will be assessed for the following regions: extremely nasal, slightly nasal, optimum, slightly temporal, extremely nasal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lens Fit - Movement</measure>
    <time_frame>1 week</time_frame>
    <description>Lens movement assessed using the following evaluations: extremely inadequate, slightly inadequate, optimum, slightly excessive, extremely excessive.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lens Surface - Deposition</measure>
    <time_frame>1 week</time_frame>
    <description>Lens surface will be assessed using Grades 0-4, 0=normal, 1=trace, 2=mild, 3=moderate, 4=severe</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lens Surface - Wettability</measure>
    <time_frame>1 week</time_frame>
    <description>Lens wettability will be assessed using Grades 0-4, 0=normal, 1=trace, 2=mild, 3=moderate, 4=severe</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Acuity</measure>
    <time_frame>1 week</time_frame>
    <description>Visual acuity will be assessed by LogMAR.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>somofilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects are randomized to wear somofilcon A for one week during the cross over study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>nelfilcon A II 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects are randomized to wear nelfilcon A II 2 for one week during the cross over study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>omafilcon A ll 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects are randomized to wear omafilcon A ll 2 for one week during the cross over study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>somofilcon A</intervention_name>
    <description>contact lens</description>
    <arm_group_label>somofilcon A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>nelfilcon A II 2</intervention_name>
    <description>contact lens</description>
    <arm_group_label>nelfilcon A II 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>omafilcon A ll 2</intervention_name>
    <description>contact lens</description>
    <arm_group_label>omafilcon A ll 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects will only be eligible for the study if:

               1. They are of legal age (18) and capacity to volunteer.

               2. They understand their rights as a research subject and are willing and able to
                  sign a Statement of Informed Consent.

               3. They are willing and able to follow the protocol.

               4. They agree not to participate in other clinical research for the duration of this
                  study.

               5. They have a contact lens spherical prescription between -1.00 to - 6.00D
                  (Diopters) (inclusive)

               6. They have a spectacle cylindrical correction of -0.75D or less in each eye.

               7. At dispensing, they can attain at least 0.10 logMAR distance high contrast visual
                  acuity in each eye with the study lenses within the available power range.

               8. They currently use soft contact lenses or have done so in the previous six
                  months.

               9. They are willing to comply with the wear schedule (at least five days per week
                  and for at least eight hours per day).

        Exclusion Criteria:

          -  Subjects will not be eligible to take part in the study if:

               1. They have an ocular disorder which would normally contra-indicate contact lens
                  wear.

               2. They have a systemic disorder which would normally contra-indicate contact lens
                  wear.

               3. They are using any topical medication such as eye drops or ointment.

               4. They have had cataract surgery.

               5. They have had corneal refractive surgery.

               6. They have any corneal distortion resulting from previous hard or rigid lens wear
                  or have keratoconus.

               7. They are pregnant or breast-feeding.

               8. They have any ocular abnormality which would, in the opinion of the investigator,
                  normally contraindicate contact lens wear.

               9. They have any infectious disease which would, in the opinion of the investigator,
                  contraindicate contact lens wear or pose a risk to study personnel; or they have
                  any immunosuppressive disease (e.g. HIV), or a history of anaphylaxis or severe
                  allergic reaction.

              10. They have taken part in any other contact lens or care solution clinical trial or
                  research, within two weeks prior to starting this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carole Maldonado-Codinal, PhD, FAAO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Eurolens Research, University of Manchester</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Eurolens Research - The University of Manchester</name>
      <address>
        <city>Manchester</city>
        <zip>M13 9PL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>September 29, 2016</study_first_submitted>
  <study_first_submitted_qc>September 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2016</study_first_posted>
  <results_first_submitted>October 17, 2017</results_first_submitted>
  <results_first_submitted_qc>April 1, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">June 26, 2019</results_first_posted>
  <last_update_submitted>October 15, 2019</last_update_submitted>
  <last_update_submitted_qc>October 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>55 subjects were recruited for the study, 51 subjects were enrolled and 50 subjects completed the initial follow up visit.</recruitment_details>
      <pre_assignment_details>Subjects are randomized to wear each lens brand for one week in a random sequence.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Somofilcon A, Nelfilcon A II 2, Omafilcon A II 2</title>
          <description>Subjects are randomized to wear somofilcon A pair of lenses for one week during the crossover study then nelfilcon A II2, then omafilcon A II 2 lenses for one week each.</description>
        </group>
        <group group_id="P2">
          <title>Somofilcon A, Omafilcon A II 2, Nelfilcon A II 2</title>
          <description>Subjects are randomized to wear somofilcon A pair of lenses for one week during the cross-over study then omafilcon A II 2, then nelfilcon A II 2 lenses for one week each.</description>
        </group>
        <group group_id="P3">
          <title>Nelfilcon A II 2, Somofilcon A, Omafilcon A II 2</title>
          <description>Subjects are randomized to wear nelfilcon A II 2 pair of lenses for one week during the cross-over study then Somofilcon A, then Omafilcon A II 2 lenses for one week each.</description>
        </group>
        <group group_id="P4">
          <title>Nelfilcon A II 2, Omafilcon A II 2, Somofilcon A</title>
          <description>Subjects are randomized to wear nelfilcon A II 2 pair of lenses for one week during the cross-over study then Omafilcon A II 2, then Somofilcon A, lenses for one week each.</description>
        </group>
        <group group_id="P5">
          <title>Omafilcon A II 2, Nelficon A II 2, Somofilcon A</title>
          <description>Subjects are randomized to wear omafilcon A II 2 pair of lenses for one week during the cross-over study then nelfilcon A II 2, then Somofilcon A lenses for one week each.</description>
        </group>
        <group group_id="P6">
          <title>Omafilcon A II 2, Somofilcon A, Nelfilcon A II 2</title>
          <description>Subjects are randomized to wear omafilcon A II 2 pair of lenses for one week during the cross-over study then Somofilcon A, then nelfilcon A II 2 lenses for one week each.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Dispense 1</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="7"/>
                <participants group_id="P4" count="6"/>
                <participants group_id="P5" count="13"/>
                <participants group_id="P6" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="7"/>
                <participants group_id="P4" count="6"/>
                <participants group_id="P5" count="12"/>
                <participants group_id="P6" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Unacceptable Lens Fit</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Dispense 2</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="7"/>
                <participants group_id="P4" count="6"/>
                <participants group_id="P5" count="13"/>
                <participants group_id="P6" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="7"/>
                <participants group_id="P4" count="6"/>
                <participants group_id="P5" count="12"/>
                <participants group_id="P6" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Unscceptable lens fit</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Dispense 3</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="7"/>
                <participants group_id="P4" count="6"/>
                <participants group_id="P5" count="13"/>
                <participants group_id="P6" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="7"/>
                <participants group_id="P4" count="6"/>
                <participants group_id="P5" count="12"/>
                <participants group_id="P6" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Unacceptable Lens Fit</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>55 subjects were recruited for the study with 50 subjects completing initial follow up visit. 5 subjects were ineligible to be dispensed with lenses for sphere out of range or cylinder out of range.</population>
      <group_list>
        <group group_id="B1">
          <title>Overall Study</title>
          <description>Total participants</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="55"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35.6" spread="12.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Ocular Physiology</title>
        <description>Ocular physiology assessment of by biomicroscopy (Scale 0-4, 0.25 steps, 0=normal, 4=severe).</description>
        <time_frame>1 week</time_frame>
        <population>Protocol deviations and discontinuations account for difference in analysis population</population>
        <group_list>
          <group group_id="O1">
            <title>Somofilcon A</title>
            <description>Subjects are randomized to wear somofilcon A for one week during the cross over study.
somofilcon A: contact lens</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A II 2</title>
            <description>Subjects are randomized to wear nelfilcon A II 2 for one week during the cross over study.
nelfilcon A II 2: contact lens</description>
          </group>
          <group group_id="O3">
            <title>Omafilcon A ll 2</title>
            <description>Subjects are randomized to wear omafilcon A ll 2 for one week during the cross over study.
omafilcon A ll 2: contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Ocular Physiology</title>
          <description>Ocular physiology assessment of by biomicroscopy (Scale 0-4, 0.25 steps, 0=normal, 4=severe).</description>
          <population>Protocol deviations and discontinuations account for difference in analysis population</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="48"/>
                <count group_id="O3" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Conjunctival Hyperemia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.76" spread="0.26"/>
                    <measurement group_id="O2" value="0.79" spread="0.31"/>
                    <measurement group_id="O3" value="0.78" spread="0.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Limbal Hyperaemia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.63" spread="0.24"/>
                    <measurement group_id="O2" value="0.66" spread="0.30"/>
                    <measurement group_id="O3" value="0.65" spread="0.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Corneal Vascularization</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.11"/>
                    <measurement group_id="O2" value="0.05" spread="0.10"/>
                    <measurement group_id="O3" value="0.06" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Microcysts</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.00"/>
                    <measurement group_id="O2" value="0.00" spread="0.00"/>
                    <measurement group_id="O3" value="0.00" spread="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oedema</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.00"/>
                    <measurement group_id="O2" value="0.00" spread="0.00"/>
                    <measurement group_id="O3" value="0.00" spread="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Corneal Staining</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.33" spread="0.42"/>
                    <measurement group_id="O2" value="0.42" spread="0.43"/>
                    <measurement group_id="O3" value="0.26" spread="0.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Conjunctival Staining</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.37" spread="0.65"/>
                    <measurement group_id="O2" value="0.41" spread="0.43"/>
                    <measurement group_id="O3" value="0.23" spread="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Paipliiary Conjunctivitis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.95" spread="0.28"/>
                    <measurement group_id="O2" value="0.88" spread="0.35"/>
                    <measurement group_id="O3" value="0.93" spread="0.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Lens Fit - Horizontal Centration</title>
        <description>Horizontal centration will be assessed for the following regions: extremely nasal, slightly nasal, optimum, slightly temporal, extremely temporal.</description>
        <time_frame>1 week</time_frame>
        <population>Protocol deviations and discontinuations account for difference in analysis population</population>
        <group_list>
          <group group_id="O1">
            <title>Somofilcon A</title>
            <description>Subjects are randomized to wear somofilcon A for one week during the cross over study.
somofilcon A: contact lens</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A II 2</title>
            <description>Subjects are randomized to wear nelfilcon A II 2 for one week during the cross over study.
nelfilcon A II 2: contact lens</description>
          </group>
          <group group_id="O3">
            <title>Omafilcon A ll 2</title>
            <description>Subjects are randomized to wear omafilcon A ll 2 for one week during the cross over study.
omafilcon A ll 2: contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Lens Fit - Horizontal Centration</title>
          <description>Horizontal centration will be assessed for the following regions: extremely nasal, slightly nasal, optimum, slightly temporal, extremely temporal.</description>
          <population>Protocol deviations and discontinuations account for difference in analysis population</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="48"/>
                <count group_id="O3" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Extremely Nasal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Slightly Nasal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Optimum</title>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="28"/>
                    <measurement group_id="O3" value="26"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Slightly Temporal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                    <measurement group_id="O2" value="17"/>
                    <measurement group_id="O3" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Extremely Temporal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Lens Fit - Vertical Centration</title>
        <description>Vertical centration will be assessed for the following regions: extremely nasal, slightly nasal, optimum, slightly temporal, extremely nasal.</description>
        <time_frame>1 week</time_frame>
        <population>Protocol deviations and discontinuations account for difference in analysis population</population>
        <group_list>
          <group group_id="O1">
            <title>Somofilcon A</title>
            <description>Subjects are randomized to wear somofilcon A for one week during the cross over study.
somofilcon A: contact lens</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A II 2</title>
            <description>Subjects are randomized to wear nelfilcon A II 2 for one week during the cross over study.
nelfilcon A II 2: contact lens</description>
          </group>
          <group group_id="O3">
            <title>Omafilcon A ll 2</title>
            <description>Subjects are randomized to wear omafilcon A ll 2 for one week during the cross over study.
omafilcon A ll 2: contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Lens Fit - Vertical Centration</title>
          <description>Vertical centration will be assessed for the following regions: extremely nasal, slightly nasal, optimum, slightly temporal, extremely nasal.</description>
          <population>Protocol deviations and discontinuations account for difference in analysis population</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="48"/>
                <count group_id="O3" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Extremely Nasal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Slightly Nasal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="20"/>
                    <measurement group_id="O3" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Optimum</title>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="22"/>
                    <measurement group_id="O3" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Slightly Temporal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Extremely Temporal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Lens Fit - Corneal Coverage</title>
        <description>Corneal coverage will be assessed for the following regions: extremely nasal, slightly nasal, optimum, slightly temporal, extremely nasal.</description>
        <time_frame>1 week</time_frame>
        <population>Protocol deviations and discontinuations account for difference in analysis population</population>
        <group_list>
          <group group_id="O1">
            <title>Somofilcon A</title>
            <description>Subjects are randomized to wear somofilcon A for one week during the cross over study.
somofilcon A: contact lens</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A II 2</title>
            <description>Subjects are randomized to wear nelfilcon A II 2 for one week during the cross over study.
nelfilcon A II 2: contact lens</description>
          </group>
          <group group_id="O3">
            <title>Omafilcon A ll 2</title>
            <description>Subjects are randomized to wear omafilcon A ll 2 for one week during the cross over study.
omafilcon A ll 2: contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Lens Fit - Corneal Coverage</title>
          <description>Corneal coverage will be assessed for the following regions: extremely nasal, slightly nasal, optimum, slightly temporal, extremely nasal.</description>
          <population>Protocol deviations and discontinuations account for difference in analysis population</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="48"/>
                <count group_id="O3" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Extremely Nasal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Slightly Nasal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Optimum</title>
                  <measurement_list>
                    <measurement group_id="O1" value="46"/>
                    <measurement group_id="O2" value="39"/>
                    <measurement group_id="O3" value="41"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Slightly Temporal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Extremely Temporal</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Lens Fit - Movement</title>
        <description>Lens movement assessed using the following evaluations: extremely inadequate, slightly inadequate, optimum, slightly excessive, extremely excessive.</description>
        <time_frame>1 week</time_frame>
        <population>Protocol deviations and discontinuations account for difference in analysis population</population>
        <group_list>
          <group group_id="O1">
            <title>Somofilcon A</title>
            <description>Subjects are randomized to wear somofilcon A for one week during the cross over study.
somofilcon A: contact lens</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A II 2</title>
            <description>Subjects are randomized to wear nelfilcon A II 2 for one week during the cross over study.
nelfilcon A II 2: contact lens</description>
          </group>
          <group group_id="O3">
            <title>Omafilcon A ll 2</title>
            <description>Subjects are randomized to wear omafilcon A ll 2 for one week during the cross over study.
omafilcon A ll 2: contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Lens Fit - Movement</title>
          <description>Lens movement assessed using the following evaluations: extremely inadequate, slightly inadequate, optimum, slightly excessive, extremely excessive.</description>
          <population>Protocol deviations and discontinuations account for difference in analysis population</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="48"/>
                <count group_id="O3" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Extremely inadequate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Slightly inadequate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="19"/>
                    <measurement group_id="O3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Optimum</title>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="27"/>
                    <measurement group_id="O3" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Slightly excessive</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Extremely excessive</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Lens Surface - Deposition</title>
        <description>Lens surface will be assessed using Grades 0-4, 0=normal, 1=trace, 2=mild, 3=moderate, 4=severe</description>
        <time_frame>1 week</time_frame>
        <population>Protocol deviations and discontinuations account for difference in analysis population</population>
        <group_list>
          <group group_id="O1">
            <title>Somofilcon A</title>
            <description>Subjects are randomized to wear somofilcon A for one week during the cross over study.
somofilcon A: contact lens</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A II 2</title>
            <description>Subjects are randomized to wear nelfilcon A II 2 for one week during the cross over study.
nelfilcon A II 2: contact lens</description>
          </group>
          <group group_id="O3">
            <title>Omafilcon A ll 2</title>
            <description>Subjects are randomized to wear omafilcon A ll 2 for one week during the cross over study.
omafilcon A ll 2: contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Lens Surface - Deposition</title>
          <description>Lens surface will be assessed using Grades 0-4, 0=normal, 1=trace, 2=mild, 3=moderate, 4=severe</description>
          <population>Protocol deviations and discontinuations account for difference in analysis population</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="48"/>
                <count group_id="O3" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Grade 0</title>
                  <measurement_list>
                    <measurement group_id="O1" value="46"/>
                    <measurement group_id="O2" value="47"/>
                    <measurement group_id="O3" value="48"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Grade 1</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Grade 2</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Grade 3</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Grade 4</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Lens Surface - Wettability</title>
        <description>Lens wettability will be assessed using Grades 0-4, 0=normal, 1=trace, 2=mild, 3=moderate, 4=severe</description>
        <time_frame>1 week</time_frame>
        <population>Protocol deviations and discontinuations account for difference in analysis population</population>
        <group_list>
          <group group_id="O1">
            <title>Somofilcon A</title>
            <description>Subjects are randomized to wear somofilcon A for one week during the cross over study.
somofilcon A: contact lens</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A II 2</title>
            <description>Subjects are randomized to wear nelfilcon A II 2 for one week during the cross over study.
nelfilcon A II 2: contact lens</description>
          </group>
          <group group_id="O3">
            <title>Omafilcon A ll 2</title>
            <description>Subjects are randomized to wear omafilcon A ll 2 for one week during the cross over study.
omafilcon A ll 2: contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Lens Surface - Wettability</title>
          <description>Lens wettability will be assessed using Grades 0-4, 0=normal, 1=trace, 2=mild, 3=moderate, 4=severe</description>
          <population>Protocol deviations and discontinuations account for difference in analysis population</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="48"/>
                <count group_id="O3" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Grade 0</title>
                  <measurement_list>
                    <measurement group_id="O1" value="37"/>
                    <measurement group_id="O2" value="44"/>
                    <measurement group_id="O3" value="43"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Grade 1</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Grade 2</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Grade 3</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Grade 4</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Visual Acuity</title>
        <description>Visual acuity will be assessed by LogMAR.</description>
        <time_frame>1 week</time_frame>
        <population>Protocol deviations and discontinuations account for difference in analysis population</population>
        <group_list>
          <group group_id="O1">
            <title>Somofilcon A</title>
            <description>Subjects are randomized to wear somofilcon A for one week during the cross over study.
somofilcon A: contact lens</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A II 2</title>
            <description>Subjects are randomized to wear nelfilcon A II 2 for one week during the cross over study.
nelfilcon A II 2: contact lens</description>
          </group>
          <group group_id="O3">
            <title>Omafilcon A ll 2</title>
            <description>Subjects are randomized to wear omafilcon A ll 2 for one week during the cross over study.
omafilcon A ll 2: contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Acuity</title>
          <description>Visual acuity will be assessed by LogMAR.</description>
          <population>Protocol deviations and discontinuations account for difference in analysis population</population>
          <units>LogMAR</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="48"/>
                <count group_id="O3" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>High Contrast</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.11" spread="0.08"/>
                    <measurement group_id="O2" value="-0.13" spread="0.08"/>
                    <measurement group_id="O3" value="-0.11" spread="0.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Low Contrast</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.18" spread="0.10"/>
                    <measurement group_id="O2" value="0.17" spread="0.11"/>
                    <measurement group_id="O3" value="0.18" spread="0.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Subjects were randomized to wear each pair of lenses (Somofilcon A, Nelfilcon A II 2, Omafilcon A II 2 at a random sequence) for One- Week in a random sequence, assessed overall for up to 4 weeks.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Somofilcon A</title>
          <description>Subjects are randomized to wear Somofilcon A for one week at random sequence</description>
        </group>
        <group group_id="E2">
          <title>Nelfilcon A II 2</title>
          <description>Subjects are randomized to wear Nelfilcon A II 2 for one week at random sequence</description>
        </group>
        <group group_id="E3">
          <title>Omafilcon A II 2</title>
          <description>Subjects are randomized to wear Omafilcon A II 2 for one week at random sequence</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="49"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="48"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Common cold</sub_title>
                <description>Non-ocular adverse events reported during the study</description>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="49"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="48"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jose Vega, O.D., MSc., FAAO</name_or_title>
      <organization>CooperVision Inc.</organization>
      <phone>9256213761</phone>
      <email>jvega2@coopervision.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

